Vanguard Fiduciary Trust
NMTC icon

Vanguard Fiduciary Trust’s NeuroOne Medical Technologies NMTC Stock Holding History

Vanguard Fiduciary Trust’s Portfolio NMTC Stock Details NMTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$149K Buy
49,018
+338
+0.7% +$1.38K ﹤0.01% 3651
2026
Q1 		$227K Buy
+48,680
New +$234K ﹤0.01% 3477

Other funds holding NMTC

BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BA
Bard Associates Chicago, Illinois $451M AUM 66.6% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Fiduciary Trust's NMTC Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its NeuroOne Medical Technologies (NMTC) stake by 0.69% in Q2 2026, buying an estimated $1.38K and bringing the position to 49,018 shares worth $149K. The position accounts for ﹤0.01% of the portfolio, ranked #3651.

Vanguard Fiduciary Trust first reported a position in NMTC in Q1 2026 and has held it in 2 quarters since. The position peaked at $227K in Q1 2026. 27 funds tracked by Wall St. Rank hold NMTC as of Q2 2026.

  • Vanguard Fiduciary Trust held 49,018 shares of NeuroOne Medical Technologies worth $149K as of Q2 2026.
  • Vanguard Fiduciary Trust bought 338 NeuroOne Medical Technologies shares in Q2 2026, an estimated $1.38K.
  • NeuroOne Medical Technologies made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3651 holding.
  • Vanguard Fiduciary Trust first reported a position in NeuroOne Medical Technologies in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's NeuroOne Medical Technologies position peaked at $227K in Q1 2026.
  • 27 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.